Nikolay K Shakhpazyan

Dr. Nikolay K Shakhpazyan

Cliniical Pathology, Avtsyn Research Institute of Human Morphology of Federal state budgetary scientific institution "Petrovsky National Research Centre of Surgery", Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
SDSiarhei Dabravolski
Siarhei Dabravolski
Vasily N SukhorukovVasily N Sukhorukov
Vasily N Sukhorukov
VKVladislav A. Kalmykov
Vladislav A. Kalmykov
AGAndrey Grechko
Andrey Grechko
NSNikolay K Shakhpazyan
Nikolay K Shakhpazyan
Alexander N. OrekhovAlexander N. Orekhov
Alexander N. Orekhov
Kruppel like factor 2 (KLF2) is a mechanosensitive transcription factor participating in the regulation of vascular endothelial cells metabolism. Activating KLF2 in endothelial cells induces eNOS (endothelial nitric oxide synthase) expression, subsequent NO (nitric oxide) release, and vasodilatory effect. In addition, many KLF2-regulated genes participate in the anti-thrombotic, antioxidant, and anti-inflammatory activities, thereby preventing atherosclerosis development and progression. In this review, we summarise recent evidence suggesting that KLF2 plays a major role in regulating atheroprotective effects in endothelial cells. We also discuss several recently identified repurposed drugs and natural plant-based bioactive compounds with KLF2-mediated atheroprotective activities. Herein, we present a comprehensive overview of the role of KLF2 in atherosclerosis and as a pharmacological target for different drugs and natural compounds and highlight the potential application of these phytochemicals for the treatment of atherosclerosis.

1 January 2022 in Biomarker Insights
Verified
Journal Article
Open access
OPOlesya A Puchenkova
Olesya A Puchenkova
VSVladislav Soldatov
Vladislav Soldatov
ABAndrei E Belykh
Andrei E Belykh
OBOlgaYu Bushueva
OlgaYu Bushueva
Gennadii PiavchenkoGennadii Piavchenko
Gennadii Piavchenko
MPMikhail V Pokrovskiy
Mikhail V Pokrovskiy
Abdominal aortic aneurysm (AAA) is a potentially life-threatening disorder with a mostly asymptomatic course where the abdominal aorta is weakened and bulged. Cytokines play especially important roles (both positive and negative) among the molecular actors of AAA development. All the inflammatory cascades, extracellular matrix degradation and vascular smooth muscle cell apoptosis are driven by cytokines. Previous studies emphasize an altered expression and a changed epigenetic regulation of key cytokines in AAA tissue samples. Such cytokines as IL-6, IL-10, IL-12, IL-17, IL-33, IL-1β, TGF-β, TNF-α, IFN-γ, and CXCL10 seem to be crucial in AAA pathogenesis. Some data obtained in animal studies show a protective function of IL-10, IL-33, and canonical TGF-β signaling, as well as a dual role of IL-4, IFN-γ and CXCL10, while TNF-α, IL-1β, IL-6, IL-12/IL-23, IL-17, CCR2, CXCR2, CXCR4 and the TGF-β noncanonical pathway are believed to aggravate the disease. Altogether data highlight significance of cytokines as informative markers and predictors of AAA. Pathologic serum/plasma concentrations of IL-1β, IL-2, IL-6, TNF-α, IL-10, IL-8, IL-17, IFN-γ, and PDGF have been already found in AAA patients. Some of the changes correlate with the size of aneurysms. Moreover, the risk of AAA is associated with polymorphic variants of genes encoding cytokines and their receptors: CCR2 (rs1799864), CCR5 (Delta-32), IL6 (rs1800796 and rs1800795), IL6R (rs12133641), IL10 (rs1800896), TGFB1 (rs1800469), TGFBR1 (rs1626340), TGFBR2 (rs1036095, rs4522809, rs1078985), and TNFA (rs1800629). Finally, 5 single-nucleotide polymorphisms in gene coding latent TGF-β-binding protein ( LTBP4) and an allelic variant of TGFB3 are related to a significantly slower AAA annual growth rate.

Verified
Journal Article
Open access
PDF file
NMNatalia V Mushenkova
Natalia V Mushenkova
NNNikita G Nikiforov
Nikita G Nikiforov
NSNikolay K Shakhpazyan
Nikolay K Shakhpazyan
VOVarvara Orekhova
Varvara Orekhova
НСНиколай Садыхов
Николай Садыхов
Alexander N. OrekhovAlexander N. Orekhov
Alexander N. Orekhov
Chronic inflammation is implicated in numerous human pathologies. In particular, low-grade inflammation is currently recognized as an important mechanism of osteoarthritis (OA), at least in some patients. Among the signs of the inflammatory process are elevated macrophage numbers detected in the OA synovium compared to healthy controls. High macrophage counts also correlate with clinical symptoms of the disease. Macrophages are central players in the development of chronic inflammation, pain, cartilage destruction, and bone remodeling. However, macrophages are also involved in tissue repair and remodeling, including cartilage. Therefore, reduction of macrophage content in the joints correlates with deleterious effects in OA models. Macrophage population is heterogeneous and dynamic, with phenotype transitions being induced by a variety of stimuli. In order to effectively use the macrophage inflammatory circuit for treatment of OA, it is important to understand macrophage heterogeneity and interactions with surrounding cells and tissues in the joint. In this review, we discuss functional phenotypes of macrophages and specific targeting approaches relevant for OA treatment development.

27 August 2024 in Cells
Verified
Journal Article
Open access
PDF file
NSNikolay K Shakhpazyan
Nikolay K Shakhpazyan
LMLiudmila Mikhaleva
Liudmila Mikhaleva
ABArkady Bedzhanyan
Arkady Bedzhanyan
ZGZarina Gioeva
Zarina Gioeva
AMAlexander I. Mikhalev
Alexander I. Mikhalev
ABAndrey E. Biryukov
Andrey E. Biryukov
The gut microbiota plays an essential role in maintaining immune homeostasis and influencing the immune landscape within the tumor microenvironment. This review aims to elucidate the interactions between gut microbiota and tumor immune dynamics, with a focus on colorectal cancer (CRC). The review spans foundational concepts of immuno-microbial interplay, factors influencing microbiome composition, and evidence linking gut microbiota to cancer immunotherapy outcomes. Gut microbiota modulates anti-cancer immunity through several mechanisms, including enhancement of immune surveillance and modulation of inflammatory responses. Specific microbial species and their metabolic byproducts can significantly influence the efficacy of cancer immunotherapies. Furthermore, microbial diversity within the gut microbiota correlates with clinical outcomes in CRC, suggesting potential as a valuable biomarker for predicting response to immunotherapy. Conclusions: Understanding the relationship between gut microbiota and tumor immune responses offers potential for novel therapeutic strategies and biomarker development. The gut microbiota not only influences the natural history and treatment response of CRC but also serves as a critical modulator of immune homeostasis and anti-cancer activity. Further exploration into the microbiome’s role could enhance the effectiveness of existing treatments and guide the development of new therapeutic modalities.

15 February 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
NMNatalia V Mushenkova
Natalia V Mushenkova
NNNikita G Nikiforov
Nikita G Nikiforov
AMAlexandra A. Melnichenko
Alexandra A. Melnichenko
VKVladislav Kalmykov
Vladislav Kalmykov
NSNikolay K Shakhpazyan
Nikolay K Shakhpazyan
Alexander N. OrekhovAlexander N. Orekhov
Alexander N. Orekhov
Macrophages are the key inflammatory cell type involved in all stages of atherosclerosis development and progression, as demonstrated by numerous studies. Correspondingly, macrophages are currently regarded as a promising therapeutic target for the development of new treatment approaches. The macrophage population is heterogeneous and dynamic, as these cells can switch between a number of distinct functional states with pro- and anti-atherogenic activity in response to various stimuli. An atherosclerotic plaque microenvironment defined by cytokine levels, cell-to-cell interactions, lipid accumulation, hypoxia, neoangiogenesis, and intraplaque haemorrhage may guide local macrophage polarization processes within the lesion. In this review, we discuss known functional phenotypes of intraplaque macrophages and their distinct contribution to ahteroinflammation.

28 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
NSNikolay K Shakhpazyan
Nikolay K Shakhpazyan
LMLiudmila Mikhaleva
Liudmila Mikhaleva
ABArkady Bedzhanyan
Arkady Bedzhanyan
НСНиколай Садыхов
Николай Садыхов
KMKonstantin Midiber
Konstantin Midiber
Alexander N. OrekhovAlexander N. Orekhov
Alexander N. Orekhov
This comprehensive review elucidates the intricate roles of long non-coding RNAs (lncRNAs) within the colorectal cancer (CRC) microenvironment, intersecting the domains of immunity, intercellular communication, and therapeutic potential. lncRNAs, which are significantly involved in the pathogenesis of CRC, immune evasion, and the treatment response to CRC, have crucial implications in inflammation and serve as promising candidates for novel therapeutic strategies and biomarkers. This review scrutinizes the interaction of lncRNAs with the Consensus Molecular Subtypes (CMSs) of CRC, their complex interplay with the tumor stroma affecting immunity and inflammation, and their conveyance via extracellular vesicles, particularly exosomes. Furthermore, we delve into the intricate relationship between lncRNAs and other non-coding RNAs, including microRNAs and circular RNAs, in mediating cell-to-cell communication within the CRC microenvironment. Lastly, we propose potential strategies to manipulate lncRNAs to enhance anti-tumor immunity, thereby underlining the significance of lncRNAs in devising innovative therapeutic interventions in CRC.